FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method for primary treatment of combined wounds. Method for primary treatment of combined wounds using a pharmaceutical composition based on a biopolymer of chitosan involves the use of a haemostatic composition with reparative properties in the form of a sponge based on xymedone, modified chitosan, glycerol and water, wherein prior to application on wound, haemostatic sponge is moistened with solution of 3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentanecarboxylic acid in concentration of 20 mcg/ml.
EFFECT: method described above enables to accelerate wound healing.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING BURN WOUNDS USING WOUND DRESSING WITH CYTOPROTECTIVE ACTIVITY | 2024 |
|
RU2828521C1 |
HAEMOSTATIC COMPOSITION WITH REPARATIVE PROPERTIES (VERSIONS) | 2019 |
|
RU2720627C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BURN (VARIANTS) AND METHOD FOR ITS PREPARING (VARIANTS) | 2006 |
|
RU2317811C1 |
WOUND COATING | 2019 |
|
RU2706726C1 |
BACTERICIDAL ANTI-BURN BIODEGRADABLE AGENT BASED ON A COLLAGEN PHARMACEUTICAL COMPOSITION WITH LACTOFERRIN, METHODS OF PRODUCING (VERSIONS) AND PROPERTIES | 2019 |
|
RU2703284C1 |
HAEMOSTATIC AGENT BASED ON CHITOSAN SUCCINATE AND CALENDULA EXTRACT | 2019 |
|
RU2694372C1 |
WOUND-HEALING COMPOSITION | 2021 |
|
RU2794958C2 |
HYDROPHILIC PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BURNS (VERSIONS) | 2008 |
|
RU2404745C2 |
AGENT FOR TREATMENT OF WOUNDS, BURNS AND INFLAMMATORY SKIN DISEASES | 2020 |
|
RU2744545C1 |
BACTERIAL COLLAGENASE-BASE PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2166950C1 |
Authors
Dates
2024-11-26—Published
2024-03-13—Filed